Forward Citations = 22

Loading Chart...

4 inventors (with patents filed for the assignee):

Lennart Olsson (5 out of 11 patents)

Tatajna Navrenda (2 out of 2 patents)

Tatjana Naranda (1 out of 2 patents)

4. Tataina Naranda (1 out of 1 patent)

5 patents: Sort by Forward Citations

1. 7037902 - Affinity small molecules for the EPO receptor (2006-05-02),

2. 6346390 - Receptor derived peptides involved in modulation of response to ligand binding (2002-02-12),

3. 6004758 - Receptor derived peptides involved in modulation of response to ligand (1999-12-21),

4. 5952293 - Receptor derived peptides involved in inhibition of receptor (1999-09-14),

5. 5073540 - Composite binding site drugs (1991-12-17),

Company Overview

Receptron, Inc. is a biotechnology company focused on the development of novel therapeutics targeting G protein-coupled receptors (GPCRs). Our proprietary platform enables the discovery of small molecule drugs with enhanced potency and selectivity for treating a variety of diseases. With a team of experienced scientists and cutting-edge technology, we are dedicated to advancing the field of drug discovery and improving patient outcomes.

Profile summary synthesized from public USPTO records and patent filings.

Company Badge

USPTO Data Jan 1 1976 - Oct 13 2026

5 Patents

#396 in Mountain View, CA

#12,070 in California

#51,620 in US

Mountain View, CA, United States of America

Receptron, Inc.

Forward Citations = 22

4 inventors:

Lennart Olsson (5 out of 11 patents)

Tatajna Navrenda (2 out of 2 patents)

Tatjana Naranda (1 out of 2 patents)

4. Tataina Naranda (1 out of 1 patent)

IDiyas Innovation Intelligence. (2026). Company Patent Portfolio: Receptron, Inc.. Retrieved from https://idiyas.com/company/receptron

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]